FN1 and hepatocellular carcinoma: Also in HCC, another study found that fibronectin extra domain A (FN-EDA), derived from cancer-associated fibroblasts, plays a key role in promoting sorafenib resistance in hepatocellular carcinoma (HCC) [159].